$75 Million

Adaptimmune Therapeutics plc

At-the-market Offering

Adaptimmune Therapeutics plc
Adaptimmune Therapeutics is a clinical stage biopharmaceutical company focused on providing novel cell therapies to patients, particularly in solid tumors.